enVVeno Medical (NVNO) Return on Capital Employed Growth (1y) (2019 - 2026)
enVVeno Medical (NVNO) Return on Capital Employed Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 658.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 125.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -3,185.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | enVVeno Medical | 2.75 Mn | 2.75 Mn | - | -2,126.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,126.00 |
| Dec 31, 2025 | -2,020.00 |
| Sep 30, 2025 | -1,971.00 |
| Jun 30, 2025 | -1,515.00 |
| Mar 31, 2025 | -371.00 |
| Dec 31, 2024 | 1,595.00 |
| Sep 30, 2024 | 3,675.00 |
| Jun 30, 2024 | 2,643.00 |
| Mar 31, 2024 | 1,659.00 |
| Dec 31, 2023 | -890.00 |
| Sep 30, 2023 | -3,139.00 |
| Jun 30, 2023 | -3,344.00 |
| Mar 31, 2023 | -3,400.00 |
| Dec 31, 2022 | -2,961.00 |
| Sep 30, 2022 | -3,491.00 |
| Jun 30, 2022 | -2,114.00 |
| Mar 31, 2022 | 474.00 |
| Dec 31, 2021 | 13,330.00 |
| Sep 30, 2021 | 18,523.00 |
| Jun 30, 2021 | 238,153.00 |